TB Alliance

About TB Alliance

TB Alliance is a global organization dedicated to developing faster, simpler, and more effective cures for all forms of tuberculosis (TB). For 25 years, they have led efforts to discover, develop, and deliver new TB treatments, transforming drug-resistant TB therapy and working towards innovations to end TB.

Products & Services

BPaL/M Regimen:A six-month, all-oral treatment for drug-resistant TB that significantly reduces treatment duration, improves outcomes, and saves costs. It is projected to save over 190,000 lives and $1.29 billion by 2035.

Pretomanid:A key component of the BPaL regimen, used in the treatment of drug-resistant TB.

Child-Friendly Medicines:TB treatments specifically designed for children to ensure accessibility and effectiveness.

Pipeline of New TB Drugs:TB Alliance manages the largest pipeline of new TB drugs in history, focusing on innovative solutions to combat TB.

Specialties

Tuberculosis Treatment Development Drug-Resistant TB Therapy Global Health Innovation Child-Friendly TB Medicines Antimicrobial Resistance Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 17000000 MR: - FA: AUD 17 Million FAN: 17000000	D: 2024-03-24 FD: 2024-03-24	1 investors

Grant Latest

2024-03-24

$17.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Maria Beumont

Vice President, Chief Medical Officer

J

Jess Wiggs

Press Inquiries

M

Mel Spigelman

President and Chief Executive Officer

N

Nader Fotouhi

Senior Vice President, Chief Scientific Officer

S

Sandeep Juneja

Senior Vice President, Market Access

R

Robert C. Lorette

Senior Vice President, Business Development

View 80 more team members with Pro

Unlock Full Team Directory

Recent News

TB Alliance Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised